Panakes Partners is a Milan-based life sciences venture capital firm focused on early-stage healthcare investing across medtech, biotech, diagnostics, and digital health. It invests from seed through Series C, with strongest concentration around Series A and B. The firm plays a meaningful role in the European medical technology funding landscape.

Its neurotechnology exposure includes companies such as Neuromod Devices, Salvia BioElectronics, and INBRAIN Neuroelectronics, indicating selective interest in clinically relevant neuro and neuro-adjacent technologies. Panakes tends to back companies with clearer regulatory and commercial pathways rather than speculative frontier neuroscience.

Panakes invests across Europe, with some flexibility beyond the region. For neurotech founders, it is a useful target for device and diagnostics companies pursuing European regulatory and commercialization routes.